RE:RE:People forget Dr. Kellum was heavily involved in FDA phase 3Correction (my apologies)
"At least some of us are able to counter the dilution with 25-35% discounts off financing levels, 40-50% discounts off warrant exercise and new warrant issuance levels, and 2/3rd discounts off spring 2021 levels. All with no discernible changes to the LT potential ( IMHO)"
Actually the Real World Evidence that is starting to accumulate on the possible benefit of using PMX-HP Covid patients, and the recent acknowledgement of Kellum of that fact (in discussion with Ronco), suggest to me, at least, that there may in fact be a material increase in long term revenue potential slowly coming to light (under the assumption that the FDA approves PMX, and the incidence of Septic Shock is likely on the rise due to Covid). Not to mention AKI, and as a consequence the need for more equipment in hospitals, and as another consequence, the need for more Home Dialysis equipment in the future. (See my Covid/PMX post with many medical study references as it relates to PMX and Covid - including one from Ronco himself)
So I have actually raised my upside target potential, in the past 6 months...despite some annoying delays on deliverables that were promised by our CEO feller. Still disappointed that the Company doesn't seem to want to talk about it to the investment community though (Bazinga was kinda weak IMO), especially state-side (where all the demand side is, and where the vast majority of the LT revenues will be generated)
MM